Lincophenicol is an inhibitor of Escherichia coli ribosomal peptidyltransferase-catalyzed puromycin reaction.
Uses
Lincophenicol is a hybrid antibiotic that has the activity of inhibiting the puromycin reaction catalyzed by Escherichia coli ribosomal peptidyl transferase and also inhibits the binding of specific compounds to the Escherichia coli ribosome.
References
[1] Hybrids of antibiotics inhibiting protein synthesis. Synthesis and biological activity
